Hyundai Motor Group is seeking to boost domestic sales by increasing the production of its Grandeur, Palisade, GV80, and G80.
The move is meant to counter the impact of weakened exports.
Consequently, Hyundai Motor Group needs to reorganize the production schedule, increase production volume, and control the amount for export.
Other smaller automakers are also leaning on domestic sales to tide them over.
Kia Motors also plans to manufacture more of its popular models, namely the Sorento, Mohave, K5, and K7.
Hyundai Motor’s sales shrank by at least 40 percent in March as overseas sales plummeted in North America and Europe.
Losses are expected to continue in April.
But the situation in the local market has been slightly better.
Data from the Ministry of Trade, Industry and Energy revealed that domestic sales of automobiles in March went up by 10.1 percent on-year to 172,956 units.
The robust sales were attributed to stable consumer sentiment and the 70 percent exemption on consumption tax for vehicles.
GM Korea, Renault Samsung Motors, and SsangYong Motors also hope to sell more domestically.
But due to the limited local growth potential, carmakers are expected to lose market share to Hyundai Motor and its sister company Kia Motors.
As of 2019, the combined sales of Hyundai Motor and Kia Motors accounted for 70.6 percent of the local market.
SsangYong Motors was the only carmaker among the five to record negative growth in March due to fierce competition in SUVs and a lack of backing from its parent company, Mahindra & Mahindra.


Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Standard Chartered Expands Hedge Fund Access for Wealth Clients
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate
SK Hynix Shares Surge on Record $28.6 Billion Buyback
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Alibaba Shares Fall as AI Spending Hits Profit
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks 



